...
首页> 外文期刊>Clinical Science >Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers
【24h】

Circulating microRNAs: emerging biomarkers for diagnosis and prognosis in patients with gastrointestinal cancers

机译:循环微RNA:用于胃肠道癌患者诊断和预后的新兴生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

To identify novel non-invasive biomarkers for improved detection, risk assessment and prognostic evaluation of cancer, expression profiles of circulating microRNAs are currently under evaluation. Circulating microRNAs are highly promising candidates in this context, as they present some key characteristics for cancer biomarkers: they are tissue-specific with reproducible expression and consistency among individuals from the same species, they are potentially derived directly from the tumour and therefore might correlate with tumour progression and recurrence, and they are bound to proteins or contained in subcellular particles, such as microvesicles or exosomes, making them highly stable and resistant to degradation. The present review highlights the origin of circulating microRNAs, their stability in blood samples, and techniques to isolate exosomal microRNAs, and then addresses the current evidence supporting potential clinical applications of circulating miRNAs for diagnostic and prognostic purposes.
机译:为了鉴定新的非侵入性生物标记物以改善癌症的检测,风险评估和预后评估,目前正在评估循环微RNA的表达谱。在这种情况下,循环微RNA是非常有前途的候选基因,因为它们具有癌症生物标志物的一些关键特征:它们是组织特异性的,在相同物种的个体之间具有可再现的表达和一致性,它们可能直接来源于肿瘤,因此可能与肿瘤相关肿瘤的进展和复发,它们与蛋白质结合或包含在亚细胞颗粒(如微泡或外泌体)中,使其高度稳定并具有抗降解性。本综述重点介绍了循环微RNA的起源,其在血样中的稳定性以及分离外泌体微RNA的技术,然后阐述了支持循环微RNA用于诊断和预后目的潜在临床应用的当前证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号